Inhibitor screening of Spike variants reveals the heterogeneity of neutralizing antibodies to COVID-19 infection and vaccination
Xiaomei Zhang, Mei Zheng, Te Liang, Haijian Zhou, Hongye Wang, Jiahui Zhang, Jing Ren, Huoying Peng, Siping Li, Haodong Bian, Chundi Wei, Shangqi Yin, Chaonan He, Ying Han, Minghui Li, Xuexin Hou, Jie Zhang, Liangzhi Xie, Jing Lv, Biao Kan, Yajie Wang, Xiaobo Yu
doi: https://doi.org/10.1101/2021.05.15.21257254
Xiaomei Zhang
1State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences-Beijing (PHOENIX Center), Beijing Institute of Lifeomics, Beijing, 102206, China
Mei Zheng
2Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing, China
3Department of Research Ward, Beijing Ditan Hospital, Capital Medical University, Beijing, China
5Joint Laboratory for Pathogen Identification of ICDC and Ditan Hospital, Beijing, 102206, China
Te Liang
1State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences-Beijing (PHOENIX Center), Beijing Institute of Lifeomics, Beijing, 102206, China
Haijian Zhou
4State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China
5Joint Laboratory for Pathogen Identification of ICDC and Ditan Hospital, Beijing, 102206, China
Hongye Wang
1State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences-Beijing (PHOENIX Center), Beijing Institute of Lifeomics, Beijing, 102206, China
Jiahui Zhang
1State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences-Beijing (PHOENIX Center), Beijing Institute of Lifeomics, Beijing, 102206, China
Jing Ren
1State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences-Beijing (PHOENIX Center), Beijing Institute of Lifeomics, Beijing, 102206, China
Huoying Peng
1State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences-Beijing (PHOENIX Center), Beijing Institute of Lifeomics, Beijing, 102206, China
Siping Li
1State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences-Beijing (PHOENIX Center), Beijing Institute of Lifeomics, Beijing, 102206, China
Haodong Bian
1State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences-Beijing (PHOENIX Center), Beijing Institute of Lifeomics, Beijing, 102206, China
Chundi Wei
1State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences-Beijing (PHOENIX Center), Beijing Institute of Lifeomics, Beijing, 102206, China
Shangqi Yin
2Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing, China
3Department of Research Ward, Beijing Ditan Hospital, Capital Medical University, Beijing, China
5Joint Laboratory for Pathogen Identification of ICDC and Ditan Hospital, Beijing, 102206, China
Chaonan He
2Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing, China
3Department of Research Ward, Beijing Ditan Hospital, Capital Medical University, Beijing, China
5Joint Laboratory for Pathogen Identification of ICDC and Ditan Hospital, Beijing, 102206, China
Ying Han
2Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing, China
3Department of Research Ward, Beijing Ditan Hospital, Capital Medical University, Beijing, China
5Joint Laboratory for Pathogen Identification of ICDC and Ditan Hospital, Beijing, 102206, China
Minghui Li
4State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China
5Joint Laboratory for Pathogen Identification of ICDC and Ditan Hospital, Beijing, 102206, China
Xuexin Hou
4State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China
5Joint Laboratory for Pathogen Identification of ICDC and Ditan Hospital, Beijing, 102206, China
Jie Zhang
6Beijing Key Laboratory of Monoclonal Antibody Research and Development, Sino Biological, Inc., Beijing, 100176, China
Liangzhi Xie
6Beijing Key Laboratory of Monoclonal Antibody Research and Development, Sino Biological, Inc., Beijing, 100176, China
Jing Lv
7Gobond Testing Technology (Beijing) Co., Ltd., Beijing, 102629, China
Biao Kan
4State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China
5Joint Laboratory for Pathogen Identification of ICDC and Ditan Hospital, Beijing, 102206, China
Yajie Wang
2Department of Clinical Laboratory, Beijing Ditan Hospital, Capital Medical University, Beijing, China
3Department of Research Ward, Beijing Ditan Hospital, Capital Medical University, Beijing, China
5Joint Laboratory for Pathogen Identification of ICDC and Ditan Hospital, Beijing, 102206, China
Xiaobo Yu
1State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences-Beijing (PHOENIX Center), Beijing Institute of Lifeomics, Beijing, 102206, China
Article usage
Posted May 18, 2021.
Inhibitor screening of Spike variants reveals the heterogeneity of neutralizing antibodies to COVID-19 infection and vaccination
Xiaomei Zhang, Mei Zheng, Te Liang, Haijian Zhou, Hongye Wang, Jiahui Zhang, Jing Ren, Huoying Peng, Siping Li, Haodong Bian, Chundi Wei, Shangqi Yin, Chaonan He, Ying Han, Minghui Li, Xuexin Hou, Jie Zhang, Liangzhi Xie, Jing Lv, Biao Kan, Yajie Wang, Xiaobo Yu
medRxiv 2021.05.15.21257254; doi: https://doi.org/10.1101/2021.05.15.21257254
Inhibitor screening of Spike variants reveals the heterogeneity of neutralizing antibodies to COVID-19 infection and vaccination
Xiaomei Zhang, Mei Zheng, Te Liang, Haijian Zhou, Hongye Wang, Jiahui Zhang, Jing Ren, Huoying Peng, Siping Li, Haodong Bian, Chundi Wei, Shangqi Yin, Chaonan He, Ying Han, Minghui Li, Xuexin Hou, Jie Zhang, Liangzhi Xie, Jing Lv, Biao Kan, Yajie Wang, Xiaobo Yu
medRxiv 2021.05.15.21257254; doi: https://doi.org/10.1101/2021.05.15.21257254
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)